
At Sanome, our mission is to build a clinical co-pilot that supports clinicians identify patient health changes earlier. We do this because healthcare demand is rapidly outpacing capacity, and the only way to address this growing gap is early detection and prevention. We aim to combine healthcare data and translate it into powerful insights that support clinical decision-making. We host a multimodal generative AI platform that translates any type of data into clinical insights. Our platform easily integrates into clinical workflows and IT systems. We are currently undergoing regulatory review as a class IIb software-as-a-medical device (SaMD) for our first product offering. Our long term vision is to build your human digital twin that understands your health and informs clinicians about any health changes.

At Sanome, our mission is to build a clinical co-pilot that supports clinicians identify patient health changes earlier. We do this because healthcare demand is rapidly outpacing capacity, and the only way to address this growing gap is early detection and prevention. We aim to combine healthcare data and translate it into powerful insights that support clinical decision-making. We host a multimodal generative AI platform that translates any type of data into clinical insights. Our platform easily integrates into clinical workflows and IT systems. We are currently undergoing regulatory review as a class IIb software-as-a-medical device (SaMD) for our first product offering. Our long term vision is to build your human digital twin that understands your health and informs clinicians about any health changes.
Sector: Hospitals and Health Care (healthtech)
Core product: Multimodal generative-AI clinical decision support / Human Digital Twin
Regulatory status: Undergoing Class IIb SaMD (EU) regulatory review
Location: London
Seed funding: Seed round announced Jan 2024; investors include Heal Capital and Omron Ventures
Early detection and prevention in clinical care; clinical decision support embedded in workflows.
2024
Hospitals and Health Care
Round announced Jan 1, 2024; Crunchbase lists six investors and a close date of Jun 30, 2024.
“Includes institutional and strategic health investors such as Heal Capital and Omron Ventures”
| Company |
|---|